enow.com Web Search

  1. Ads

    related to: cd19 car t autoimmune

Search results

  1. Results from the WOW.Com Content Network
  2. CD19 - Wikipedia

    en.wikipedia.org/wiki/CD19

    CAR-19 T cells are more effective than anti-CD19 immunotoxins because they can proliferate and remain in the body for a longer period of time. This comes with a caveat since now CD19immune escape facilitated by splice variants, point mutations, and lineage switching can form as a major form of therapeutic resistance for patients with ALL. [38]

  3. CAR T cell - Wikipedia

    en.wikipedia.org/wiki/CAR_T_cell

    Preclinical studies developing CAR T cells with dual targeting of CD19 plus CD22 or CD19 plus CD20 have demonstrated promise, and trials studying bispecific targeting to circumvent CD19 down-regulation are ongoing. [33] In 2018, a version of CAR was developed that is referred to as SUPRA CAR, or split, universal, and programmable. [100]

  4. Lisocabtagene maraleucel - Wikipedia

    en.wikipedia.org/wiki/Lisocabtagene_maraleucel

    Lisocabtagene maraleucel, a chimeric antigen receptor (CAR) T cell (CAR-T) therapy, is the third gene therapy approved by the US Food and Drug Administration (FDA) for certain types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma. [6] Lisocabtagene maraleucel was approved for medical use in the United States in February 2021 ...

  5. Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial ...

    lite.aol.com/tech/story/0022/20250112/9330425.htm

    CB-010, a clinical-stage allogeneic anti-CD19 CAR-T cell therapy for lupus. Caribou expanded the CB-010 program following clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for CB-010 in LN and ERL. The FDA granted Fast Track designation to CB-010 for refractory systemic lupus ...

  6. Obecabtagene autoleucel - Wikipedia

    en.wikipedia.org/wiki/Obecabtagene_autoleucel

    Obecabtagene autoleucel, sold under the brand name Aucatzyl, is an anti-cancer medication used for the treatment of acute lymphoblastic leukemia. [1] [2] It is a CD19-directed genetically modified autologous T-cell immunotherapy.

  7. Lyell to Highlight Vision for its Next-Generation CAR T-Cell ...

    lite.aol.com/tech/story/0022/20250109/9329168.htm

    Lyell’s lead program, IMPT-314, is a dual-targeting CD19/CD20 CAR T-cell product candidate designed to increase complete response rates and prolong the duration of the responses as compared to the currently approved CD19‑targeted CAR therapies for the treatment of large B-cell lymphoma.

  1. Ads

    related to: cd19 car t autoimmune